Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
-
Search results from the "OB_OTC" table for query
on "020704."
| Active Ingredient: | LORATADINE |
| Dosage Form;Route: | TABLET, ORALLY DISINTEGRATING; ORAL |
| Proprietary Name: | CLARITIN REDITABS |
| Applicant: | SCHERING PLOUGH |
| Strength: | 10MG |
| Application Number: | N020704 |
| Product Number: | 002 |
| Approval Date: | Nov 27, 2002 |
| Reference Listed Drug | Yes |
| RX/OTC/DISCN: | OTC |
| Patent and Exclusivity Info for this product: | View |
|
|
|
| Active Ingredient: | LORATADINE |
| Dosage Form;Route: | TABLET, ORALLY DISINTEGRATING; ORAL |
| Proprietary Name: | CLARITIN HIVES RELIEF REDITAB |
| Applicant: | SCHERING PLOUGH |
| Strength: | 10MG |
| Application Number: | N020704 |
| Product Number: | 003 |
| Approval Date: | Nov 19, 2003 |
| Reference Listed Drug | Yes |
| RX/OTC/DISCN: | OTC |
| Patent and Exclusivity Info for this product: | View |
|
|
|
Return to Electronic Orange Book Home Page
| FDA/Center for Drug Evaluation and Research |
| Office of Generic Drugs |
| Division of Labeling and Program Support |
| Update Frequency: |
| Orange Book Data - Monthly |
| Generic Drug Product Information & Patent Information - Daily |
| Orange Book Data Updated Through April, 2013 |
| Patent and Generic Drug Product Data Last Updated: May 17, 2013 |
-
